Hannah Meiselman

I support SB 455 because it establishes clear, medically grounded criteria for GLP-1 coverage and prevents insurers from using opaque or inconsistent rules to deny evidence-based treatment. Ensuring access for patients with severe obesity and related comorbidities strengthens transparency, reduces administrative friction, and aligns coverage with clinical need.